Vencanna Ventures Inc
VENI
Critical Reagent Processing Corp
CRPC
Sanu Gold Corp
SANU
Cannibble Food Tech Ltd
PLCN
Fineqia International Inc
FNQ
CA Stock MarketDetailed Quotes
VBI.H Vivione Biosciences Inc
- 0.015
- 0.0000.00%
15min DelayMarket Closed Dec 2 09:30 ET
1.03MMarket Cap-7500P/E (TTM)
0.000High0.000Low0Volume0.000Open0.015Pre Close0.00Turnover0.00052wk High0.00%Turnover Ratio68.99MShares0.00052wk Low-0.002EPS TTM1.03MFloat Cap0.000Historical HighLossP/E (Static)68.99MShs Float0.000Historical Low-0.003EPS LYR0.00%Amplitude--Dividend TTM3.75P/B1Lot Size--Div YieldTTM
Vivione Biosciences Inc Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2018 | (Q2)Jun 30, 2018 | (Q1)Mar 31, 2018 | (FY)Dec 31, 2017 | (Q4)Dec 31, 2017 | (Q3)Sep 30, 2017 | (Q2)Jun 30, 2017 | (Q1)Mar 31, 2017 | (FY)Dec 31, 2016 | (Q4)Dec 31, 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | ---- |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | -6.82%28.9K | 23.97%39.02K | 4.34%33.38K | 41.41%121.1K | 217.59%29.27K | -19.00%31.01K | -54.71%31.47K | 202.14%31.99K | -94.94%85.64K | -96.80%9.22K |
| Selling and administrative expenses | -6.82%28.9K | 32.22%38.12K | 4.34%33.38K | 41.41%121.1K | 19.66%29.27K | -12.13%31.01K | -54.51%28.83K | -14.59%31.99K | -94.71%85.64K | -92.76%24.46K |
| -General and administrative expense | -6.82%28.9K | 32.22%38.12K | 4.34%33.38K | 41.41%121.1K | 19.66%29.27K | -12.13%31.01K | -54.51%28.83K | -14.59%31.99K | -94.66%85.64K | -92.71%24.46K |
| Provision for doubtful accounts | ---- | -66.00%899 | ---- | ---- | ---- | ---- | -56.78%2.64K | ---- | ---- | ---- |
| Operating profit | 6.82%-28.9K | -23.97%-39.02K | -4.34%-33.38K | -41.41%-121.1K | -217.59%-29.27K | 19.00%-31.01K | 54.71%-31.47K | -202.14%-31.99K | 94.86%-85.64K | 97.11%-9.22K |
| Net non-operating interest income (expenses) | 0 | 99.10%-1.8K | 99.96%-62 | |||||||
| Non-operating interest expense | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | -98.53%1.8K | -99.78%62 |
| Other net income (expenses) | 47.90%-2.15K | 188.00%2.46K | 150.37%1.5K | -599.45%-10.99K | -45.92%1.54K | -139.13%-4.13K | -504.62%-2.8K | -883.11%-2.97K | -99.93%2.2K | -99.89%2.86K |
| Gain on sale of security | 29.75%-2.15K | 188.00%2.46K | 3,258.75%2.53K | -722.11%-3.35K | 949.80%2.59K | -77.33%-3.06K | -504.62%-2.8K | -121.11%-80 | -100.01%-407 | -99.99%247 |
| Special income (charges) | --0 | ---- | 64.27%-1.03K | -393.21%-7.65K | ---1.05K | ---1.07K | ---- | ---2.89K | -92.38%2.61K | ---- |
| -Less:Other special charges | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 48.57%-20.78K | ---- |
| -Less:Write off | --0 | ---- | -64.27%1.03K | -57.92%7.65K | --1.05K | --1.07K | ---- | --2.89K | --18.17K | ---- |
| Income before tax | 11.65%-31.05K | -6.65%-36.55K | 8.79%-31.89K | -54.97%-132.1K | -331.65%-27.73K | 15.79%-35.14K | 50.18%-34.27K | -210.28%-34.96K | -106.13%-85.24K | -100.29%-6.42K |
| Income tax | ||||||||||
| Earnings from equity interest net of tax | ||||||||||
| Net income | 11.65%-31.05K | -6.65%-36.55K | 8.79%-31.89K | -54.97%-132.1K | -331.65%-27.73K | 15.79%-35.14K | 50.18%-34.27K | -210.28%-34.96K | -106.09%-85.24K | -100.29%-6.42K |
| Net income continuous operations | 11.65%-31.05K | -6.65%-36.55K | 8.79%-31.89K | -54.97%-132.1K | -331.65%-27.73K | 15.79%-35.14K | 50.18%-34.27K | -210.28%-34.96K | -106.09%-85.24K | -100.29%-6.42K |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 11.65%-31.05K | -6.65%-36.55K | 8.79%-31.89K | -54.97%-132.1K | -331.65%-27.73K | 15.79%-35.14K | 50.18%-34.27K | -210.28%-34.96K | -106.09%-85.24K | -100.29%-6.42K |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | 11.65%-31.05K | -6.65%-36.55K | 8.79%-31.89K | -54.97%-132.1K | -331.65%-27.73K | 15.79%-35.14K | 50.18%-34.27K | -210.28%-34.96K | -106.09%-85.24K | -100.29%-6.42K |
| Diluted earnings per share | 11.59%-0.0005 | -6.64%-0.0005 | 9.11%-0.0005 | -56.44%-0.0019 | -497.22%-0.0004 | 17.77%-0.0005 | 51.32%-0.0005 | -209.79%-0.0005 | -106.21%-0.0012 | -100.24%-0.0001 |
| Basic earnings per share | 11.59%-0.0005 | -6.64%-0.0005 | 9.11%-0.0005 | -56.44%-0.0019 | -362.37%-0.0004 | 17.77%-0.0005 | 51.32%-0.0005 | -209.79%-0.0005 | -106.21%-0.0012 | -100.31%-0.0001 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.